Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8853439 | Ecotoxicology and Environmental Safety | 2018 | 10 Pages |
Abstract
Fluoxetine is a selective serotonin reuptake inhibitor used as an antidepressant and has been frequently detected in aquatic environments. However, its effects in fish from Asia remain relatively less studied. In this study, the topmouth gudgeon Pseudorasbora parva was exposed to 0, 50, and 200â¯Âµg/L of fluoxetine for 4â¯h and 42 d. The effects of fluoxetine on biometrics were compared to biochemical endpoints indicative of stress in different fish tissues (brain, liver, gills and intestine) following exposures. In fish exposed for 42 d, lipid peroxidation endpoints were enhanced 80% in the liver and gills. Acetylcholinesterase (AChE) activity was increased 40% after exposure to 50â¯Âµg/L and 55% at 200â¯Âµg/L following 4â¯h exposure. In contrast AChE was increased 26% (at 50â¯Âµg/L) after 42 d of exposures. Enhanced ethoxyresorufin-O-deethylase activity (EROD) was detected only in fish exposed to 50â¯Âµg/L of fluoxetine for 4â¯h. The activity of α-glucosidase (α-Glu) was also induced (at 200â¯Âµg/L) after 4â¯h of exposure. After 4â¯h of exposure, the activities of proteases in the intestine were generally inhibited at 200â¯Âµg/L. Both 4â¯h and 42 d exposures resulted in an increased hepatosomatic index (HSI) but did not affect the condition factor (CF). Our results demonstrate that fluoxetine significantly altered biochemical endpoints in P. parva after acute exposure and the morphological changes in liver size were not observed until 42â¯d of exposure.
Keywords
Related Topics
Life Sciences
Environmental Science
Environmental Chemistry
Authors
Hongxing Chen, Xiangfeng Zeng, Lei Mu, Liping Hou, Bin Yang, Jianliang Zhao, Daniel Schlenk, Wu Dong, Lingtian Xie, Qianru Zhang,